Based on the hypothesis that impaired glucose metabolism might be associated with survival outcomes independently of overt diabetes, we sought to investigate the prognostic value of routinely used glycemic parameters in a prospective study of breast cancer (BC) patients.

Ferroni, P., Riondino, S., Laudisi, A., Portarena, I., Formica, V., Alessandroni, J., et al. (2016). Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression. THE ONCOLOGIST [10.1634/theoncologist.2015-0462].

Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression

Riondino, S;ORLANDI, AUGUSTO;ROSELLI, MARIO
2016-07-07

Abstract

Based on the hypothesis that impaired glucose metabolism might be associated with survival outcomes independently of overt diabetes, we sought to investigate the prognostic value of routinely used glycemic parameters in a prospective study of breast cancer (BC) patients.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/06 - Oncologia Medica
English
Senza Impact Factor ISI
Breast cancer; Insulin; Insulin resistance; Prognostic value
Ferroni, P., Riondino, S., Laudisi, A., Portarena, I., Formica, V., Alessandroni, J., et al. (2016). Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression. THE ONCOLOGIST [10.1634/theoncologist.2015-0462].
Ferroni, P; Riondino, S; Laudisi, A; Portarena, I; Formica, V; Alessandroni, J; D'Alessandro, R; Orlandi, A; Costarelli, L; Cavaliere, F; Guadagni, F; Roselli, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/159880
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 40
social impact